eCAP - eHealth CAPsule for digestive disease diagnostic and therapy

eCAP旨在提供一种新型医疗设备，该设备将智能胶囊与电子健康平台相结合，以实现更好的诊断和患者自主疾病管理，从而改善胃肠道疾病患者的预后。我们的项目将创建一个具有多传感能力的模块化可植入胶囊，利用柔性内窥镜的微创手术方法，可以在受控时间段内进行GI生理监测。eCAP将使用全球通用的智能手机通信标准，以及云计算技术和应用程序接口来集成、处理和解释胶囊收集的纵向生理数据。该数字平台旨在通过合并患者报告的结果测量来提高标准测试数据的准确性和临床实用性。临床医生能够为患者进行个性化测试，并从这些多流数据输入中获得准确而有意义的结果，并在人工智能的帮助下进行解释。eCAP解决方案的通用性将使先进的胃肠道疾病诊断能够传播给全世界的患者和医生，包括资源匮乏的环境。在项目期间，我们将演示eCAP？胃食管反流病（GERD）是一种世界性的、常见的、极其昂贵的疾病，作为临床目标，研究其临床价值和成本节约。使用健康经济学分析的临床评估将在法国、乌克兰和肯尼亚进行，并将制定一个专门的教育计划来培训从业人员使用这项新技术。eCAP建立在我们的联盟在胃肠道疾病诊断的可植入胶囊领域多年的研发基础上。它的目标是促进胃肠道诊断从目前不可扩展的模拟版本转变为以患者为中心的电子健康工具，并使欧洲成为快速增长的用于远程患者监测的连接医疗设备领域的领导者。

eCAP aims to deliver a novel medical device which combines a smart capsule with an e-health platform for better diagnostics,patient empowered disease management and hence, improved outcomes for patients with gastrointestinal (GI) diseases. Our projectwill create a modular and implantable capsule with multi-sensing capacity that enables GI physiology monitoring for a controlledtime period, leveraging the minimally invasive surgical approach of flexible endoscopy. eCAP will use a worldwide ubiquitoussmartphone communication standard, together with cloud computing technology and application interfaces to integrate, process andinterpret longitudinal physiological data collected by the capsule. The digital platform is designed to improve the accuracy and clinicalusefulness of standard test data by incorporating patient reported outcome measures. The clinician is able to personalize the testfor the patient and receive accurate and meaningful results from this multi-stream data input with interpretation aided by ArtificialIntelligence. The universality of the eCAP solution will allow dissemination of advanced GI disease diagnostics to patients and doctorsworldwide, including low resource environments. During the project, we will demonstrate eCAP?s clinical value and cost savings usinggastroesophageal reflux disease (GERD), a worldwide, common, and extremely costly problem, as a clinical target. Clinical evaluationwith health-economics analysis will be conducted in France, Ukraine and Kenya, and a specific education program will be developedto train practitioners to use the novel technology. eCAP builds on several years of R&D by our consortium in the field of implantablecapsules for GI disease diagnostics. Its ambition is to facilitate a shift in GI diagnostics from its current unscalable analogue versionto a patient centered e-health tool and to make Europe the leader in the rapidly growing field of connected medical devices for remotepatient monitoring.